
    
      In this prospective, multi-center, single arm observational study, 413 patients with
      non-valvular atrial fibrillation intended to be implanted with a WATCHMAN device based on
      real clinical practice will be enrolled. Enrolled subjects will be followed up for 5
      years.Primary endpoints include stroke, systematic embolism, cardiovascular death, and
      procedure or device related complications, etc.
    
  